MENU
ANRO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Alto Neuroscience (ANRO) Earnings Date & Reports
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options... Show more
A.I. Advisor
published Earnings
ANRO is expected to report earnings to fall 7.69% to -60 cents per share on November 11
Q3'26
Est.
$-0.60
Q2'26
Beat
by $0.10
Q1'26
Missed
by $0.12
Q4'25
Beat
by $0.20
Q3'25
Beat
by $0.12
The last earnings report on August 12 showed earnings per share of -64 cents, beating the estimate of -75 cents. With 165.78K shares outstanding, the current market capitalization sits at 915.13M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
650 Castro Street
Phone
+1 650 200-0412
Employees
68
Web
https://www.altoneuroscience.com